These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 29369770)
1. Two New Drugs for Tardive Dyskinesia Hit the Market. Morrow T Manag Care; 2018 Jan; 27(1):35-36. PubMed ID: 29369770 [TBL] [Abstract][Full Text] [Related]
2. Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia. Davis MC; Miller BJ; Kalsi JK; Birkner T; Mathis MV N Engl J Med; 2017 Jun; 376(26):2503-2506. PubMed ID: 28489481 [No Abstract] [Full Text] [Related]
3. Tardive Dyskinesia: New Treatments Available. Limandri BJ J Psychosoc Nurs Ment Health Serv; 2019 May; 57(5):11-14. PubMed ID: 31042295 [TBL] [Abstract][Full Text] [Related]
4. Valbenazine (Ingrezza) for tardive dyskinesia. Med Lett Drugs Ther; 2017 May; 59(1521):83-84. PubMed ID: 28520698 [No Abstract] [Full Text] [Related]
5. Valbenazine for the treatment of tardive dyskinesia. Barquero N Drugs Today (Barc); 2016 Dec; 52(12):665-672. PubMed ID: 28276538 [TBL] [Abstract][Full Text] [Related]
6. Valbenazine: First Global Approval. Kim ES Drugs; 2017 Jul; 77(10):1123-1129. PubMed ID: 28578484 [TBL] [Abstract][Full Text] [Related]
7. Valbenazine as the first and only approved treatment for adults with tardive dyskinesia. Sarva H; Henchcliffe C Expert Rev Clin Pharmacol; 2018 Mar; 11(3):209-217. PubMed ID: 29338466 [TBL] [Abstract][Full Text] [Related]
8. VMAT2 Inhibitors: New Drugs for the Treatment of Tardive Dyskinesia. Kim AP; Baker DE; Levien TL Consult Pharm; 2018 Apr; 33(4):201-209. PubMed ID: 29609698 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors. Niemann N; Jankovic J Drugs; 2018 Apr; 78(5):525-541. PubMed ID: 29484607 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness and Value of 2 Novel Treatments for Tardive Dyskinesia. Atlas SJ; Agboola F; Curfman G JAMA Intern Med; 2018 Aug; 178(8):1110-1112. PubMed ID: 29913006 [No Abstract] [Full Text] [Related]